Massimo E. Martino
89133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 193 publications
The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma.
Journal: Cancers
Published: July 01, 2026
Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCy.
Journal: American journal of hematology
Published: May 27, 2026
Genomic epidemiology and phylogenomics of Magnusiomyces clavatus: a comparative analysis of novel italian and publicly available genomes.
Journal: Frontiers in cellular and infection microbiology
Published: May 04, 2026
Targeted Therapies Combined with Intensive Chemotherapy in Fit Acute Myeloid Leukemia: Past Developments, Current Evidence, and Future Therapeutic Paradigms.
Journal: Journal of clinical medicine
Published: April 24, 2026
Fludarabine-Treosulfan (FT10) Conditioning in Older AML Patients Undergoing Haploidentical Transplantation: A Prospective Italian Study With External Comparison to the Haplo-UK Reduced-Intensity Conditioning Cohort.
Journal: Transplantation and cellular therapy
Published: April 02, 2026
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo).
Journal: Bone marrow transplantation
Published: April 01, 2026
Reconsidering time from diagnosis to treatment in acute myeloid leukemia: from therapeutic urgency to biologically informed timing.
Journal: Expert review of hematology
Published: March 28, 2026
Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols.
Journal: Bone marrow transplantation
Published: March 18, 2026
A Bayesian Survival Model to Support the Selection of the Best Hematopoietic Stem Cell Donor.
Journal: Transplantation and cellular therapy
Published: March 17, 2026
Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.
Journal: Bone marrow transplantation
Published: March 02, 2026
Last Updated: 09/26/2026